Lung transplant device LungFX won FDA approval Monday for centralized ex vivo lung perfusion, a technology that reconditions ...
PaO2/FiO2 ratio and NT-proBNP were assessed at baseline, 24 hours, 3 days, and 7 days, while mPAP was measured at baseline, 24 hours, and 7 days. Safety endpoints included mortality, hemodynamic ...
Acute respiratory distress syndrome presents as hypoxia and bilateral pulmonary infiltrates on chest imaging in the absence of heart failure sufficient to account for this clinical state. Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results